Table of Contents What Are the Most Common Retatrutide Side Effects
No GLP-1 drugs suppress appetite but do not rebuild microbial diversity, SCFAs, gut barrier strength, inflammation control, or circadian metabolic rhythm
Injection site reactions are among the most frequently reported adverse effects of GLP-1 receptor agonist and related therapies, though most are mild and self-limiting
This is a synthetic tri-agonist peptide designed for laboratory research focused on multi-pathway metabolic signaling
doi:10.1021/acs.jproteome.3c00646 Tabb DL, McDonald WH, Yates JR
Eli Lilly, the company which makes Mounjaro, says "patient safety is Lilly's top priority", and that it "actively engages" in monitoring, evaluating and reporting information to regulators and prescribers.